Cited by 117Cannabis and Cannabinoid ResearchPosttraumatic Stress Disorder ResearchPsychedelics and Drug Studies

Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

Passie, Torsten, Emrich, Hinderk M., Karst, Matthias, Brandt, Simon D., Halpern, John H.·2012·Drug Testing and Analysis

Abstract

It is known from clinical studies that some patients attempt to cope with the symptoms of post‐traumatic stress disorder (PTSD) by using recreational drugs. This review presents a case report of a 19‐year‐old male patient with a spectrum of severe PTSD symptoms, such as intense flashbacks, panic attacks, and self‐mutilation, who discovered that some of his major symptoms were dramatically reduced by smoking cannabis resin. The major part of this review is concerned with the clinical and preclinical neurobiological evidence in order to offer a potential explanation of these effects on symptom reduction in PTSD. This review shows that recent studies provided supporting evidence that PTSD patients may be able to cope with their symptoms by using cannabis products. Cannabis may dampen the strength or emotional impact of traumatic memories through synergistic mechanisms that might make it easier for people with PTSD to rest or sleep and to feel less anxious and less involved with flashback memories. The presence of endocannabinoid signalling systems within stress‐sensitive nuclei of the hypothalamus, as well as upstream limbic structures (amygdala), point to the significance of this system for the regulation of neuroendocrine and behavioural responses to stress. Evidence is increasingly accumulating that cannabinoids might play a role in fear extinction and antidepressive effects. It is concluded that further studies are warranted in order to evaluate the therapeutic potential of cannabinoids in PTSD. Copyright © 2012 John Wiley & Sons, Ltd.

Integrity signals

Registry

Crossref · 10.1002/dta.1377

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Synthetic cannabinoid receptor agonists or plant-derived cannabinoids such as marijuana may possess some benefits in individuals with PTSD by helping relieve haunting nightmares and other symptoms of PTSD.

    “Such findings substantiate, at least in part, emerging evidence that synthetic cannabinoid receptor agonists50 or plant-derived cannabinoids such as marijuana51 may possess some benefits in individuals with PTSD by helping relieve haunting nightmares and other symptoms of PTSD.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H.
Affiliations
  • Harvard University (US)
  • Medizinische Hochschule Hannover (DE)
  • Liverpool John Moores University (GB)
Corresponding author
Passie, Torsten
Venue
Drug Testing and Analysis
Publisher
Wiley
Published
2012-06-26
Volume
4
Issue
7-8
Pages
649-659
ISSN
  • 1942-7603 (ISSN-L)
  • 1942-7611
OpenAlex
W1859839572
Cited by
117
References
141
Citations by year
2026: 3 · 2025: 2 · 2024: 7 · 2023: 8 · 2022: 3 · 2021: 8 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 15 · 2015: 14 · 2014: 12 · 2013: 8 · 2012: 1
FWCI
8.24
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Testing and Analysis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords
post-traumatic stress disorder, hashish, cannabinoids, flashbacks, panic attacks, self-mutilation, endocannabinoid system, amygdala, hypothalamus, fear extinction, antidepressant effects, stress response, recreational drug use
MeSH terms
Adult, Antidepressive Agents, Anxiety, Cannabinoids, Cannabis, Humans, Hypnotics and Sedatives, Male, Sleep, Stress Disorders, Post-Traumatic, Young Adult, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review